ATE555095T1 - Verfahren zur herstellung von 3-hydroxy-n-alkyl-1-cycloalkyl-6-alkyl-4-oxo-1, -dihydropyridin-2- carbonsäureamid und damit verwandten analoga - Google Patents

Verfahren zur herstellung von 3-hydroxy-n-alkyl-1-cycloalkyl-6-alkyl-4-oxo-1, -dihydropyridin-2- carbonsäureamid und damit verwandten analoga

Info

Publication number
ATE555095T1
ATE555095T1 AT05810777T AT05810777T ATE555095T1 AT E555095 T1 ATE555095 T1 AT E555095T1 AT 05810777 T AT05810777 T AT 05810777T AT 05810777 T AT05810777 T AT 05810777T AT E555095 T1 ATE555095 T1 AT E555095T1
Authority
AT
Austria
Prior art keywords
formula
alkyl
compound
dihydropyridine
oxo
Prior art date
Application number
AT05810777T
Other languages
English (en)
Inventor
Tim Tam
Regis Leung-Toung
Yanqing Zhao
Wanren Li
Yingsheng Wang
Sandra Agostino
Birenkumar Shah
Original Assignee
Apotex Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Apotex Inc filed Critical Apotex Inc
Application granted granted Critical
Publication of ATE555095T1 publication Critical patent/ATE555095T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81Amides; Imides
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
AT05810777T 2004-11-19 2005-11-17 Verfahren zur herstellung von 3-hydroxy-n-alkyl-1-cycloalkyl-6-alkyl-4-oxo-1, -dihydropyridin-2- carbonsäureamid und damit verwandten analoga ATE555095T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CA002488034A CA2488034C (en) 2004-11-19 2004-11-19 Process for the manufacture of 3-hydroxy-n-alkyl-1-cycloalkyl-6-alkyl-4-oxo-1,4-dihydropyridine-2-carboxamide and its related analogues
PCT/CA2005/001746 WO2006053429A1 (en) 2004-11-19 2005-11-17 Process for the manufacture of 3-hydroxy-n-alkyl-1-cycloalkyl-6-alkyl-4-oxo-1,4-dihydropyridine-2-carboxamide and its related analogues

Publications (1)

Publication Number Publication Date
ATE555095T1 true ATE555095T1 (de) 2012-05-15

Family

ID=36406138

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05810777T ATE555095T1 (de) 2004-11-19 2005-11-17 Verfahren zur herstellung von 3-hydroxy-n-alkyl-1-cycloalkyl-6-alkyl-4-oxo-1, -dihydropyridin-2- carbonsäureamid und damit verwandten analoga

Country Status (6)

Country Link
US (1) US7893269B2 (de)
EP (1) EP1824823B1 (de)
CN (1) CN101094834B (de)
AT (1) ATE555095T1 (de)
CA (1) CA2488034C (de)
WO (1) WO2006053429A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007041855A1 (en) * 2005-10-13 2007-04-19 Waratah Pharmaceuticals, Inc. Scyllo-inositol derivatives and their use in the treatment of diseases characterised by abnormal protein folding or aggregation or amyloid formation, deposition, accumulation or persistence
WO2010011814A1 (en) 2008-07-25 2010-01-28 Smithkline Beecham Corporation Chemical compounds
CN102245572B (zh) 2008-12-11 2015-03-25 盐野义制药株式会社 氨甲酰基吡啶酮hiv整合酶抑制剂的方法和中间体
KR101733625B1 (ko) 2008-12-11 2017-05-10 시오노기세야쿠 가부시키가이샤 카르바모일피리돈 hiv 인테그라제 억제제 및 중간체의 합성
TWI518084B (zh) 2009-03-26 2016-01-21 鹽野義製藥股份有限公司 哌喃酮與吡啶酮衍生物之製造方法
TWI582097B (zh) 2010-03-23 2017-05-11 Viiv醫療保健公司 製備胺甲醯吡啶酮衍生物及中間體之方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR78491B (de) 1982-03-24 1984-09-27 Nat Res Dev
CA1317298C (en) 1987-03-03 1993-05-04 Upjohn Company (The) Antibiotic sulfonylaminocarbonyl activated .beta.-lactams
GB9217099D0 (en) 1992-08-12 1992-09-23 British Tech Group Pharmaceutical compositions
ES2244967T3 (es) 1995-09-29 2005-12-16 Novartis Ag Nuevas hidroxipiridinonas.
GB9711093D0 (en) * 1997-05-29 1997-07-23 British Tech Group Novel orally active iron (III) chelators
US6465229B2 (en) 1998-12-02 2002-10-15 E. I. Du Pont De Nemours And Company Plant caffeoyl-coa o-methyltransferase
US6426418B1 (en) * 2001-11-02 2002-07-30 Apotex, Inc. Processes for the manufacturing of 3-hydroxy-N,1,6-trialkyl-4-oxo-1,4-dihydropyridine-2-carboxamide
CA2379370A1 (en) 2002-03-28 2003-09-28 Apotex Inc. Carboxylic acid derivatives of 3-hydroxy-4-oxo-1,4-dihydropyridine as iron chelators
NZ529657A (en) 2003-11-20 2004-07-30 Apotex Inc Iron chelating cycloalkyl derivatives of 3-hydroxy-4-pyridinones

Also Published As

Publication number Publication date
EP1824823A4 (de) 2009-09-23
WO2006053429A1 (en) 2006-05-26
CA2488034C (en) 2009-10-06
US20080096886A1 (en) 2008-04-24
CN101094834B (zh) 2012-03-07
EP1824823A1 (de) 2007-08-29
US7893269B2 (en) 2011-02-22
CN101094834A (zh) 2007-12-26
CA2488034A1 (en) 2006-05-19
EP1824823B1 (de) 2012-04-25

Similar Documents

Publication Publication Date Title
DE602005023459D1 (de) Verfahren zur herstellung und reinigung von 2-hydrocarbyl-3,3-bis(4-hydroxyaryl-phthalimidin-monomeren
IS5883A (is) Aðferð til framleiðslu á hreinu sítalóprami
ATE538085T1 (de) Verfahren zur herstellung von 2-amino-5- cyanobenzoesäurederivaten
WO2009006061A3 (en) Process for preparing 2-amino-5-cyanobenzoic acid derivatives
NZ596025A (en) [4-(6-halo-7-substituted-2,4-dioxo-1,4-dihydro-2h-quinazolin-3-yl)-phenyl]-5-chloro-thiophen-2-yl-sulfonylureas and forms and methods related thereto
KR20190013554A (ko) 아미노피리미딘 유도체의 합성에 유용한 신규의 중간체, 이의 제조방법 및 이를 이용한 아미노피리미딘 유도체의 제조방법
DE60229773D1 (de) Verfahren zur kontinuierlichen quaternisierung tertiärer amine mit einem alkylhalogenid
BRPI0408160B1 (pt) Processo para o preparo de ésteres do ácido nicotínico substituído e intermediários de enamina para uso nesse processo
KR20210066768A (ko) 광학 활성 다이아민 유도체 및 티아졸 유도체의 생산을 위한 새로운 합성경로
MXPA03005429A (es) Procedimiento para preparacion de imidazotriazinonas sustituidas con sulfonamida.
ATE555095T1 (de) Verfahren zur herstellung von 3-hydroxy-n-alkyl-1-cycloalkyl-6-alkyl-4-oxo-1, -dihydropyridin-2- carbonsäureamid und damit verwandten analoga
ATE513801T1 (de) Verfahren zur synthese von propargylatierten aminoindanderivativen
ATE455088T1 (de) Asymmetrische reduktive aminierung von ketosäurederivaten zur herstellung von aminosäurederivaten
US4822895A (en) 3-aminoazetidine, its salts and intermediates of synthesis
EP3351532A1 (de) Verfahren zur herstellung von pimavanserin
JP5618306B2 (ja) 置換4−アミノ−ピリミジンの新規合成
SK24194A3 (en) Method of preparation of aqueous solution of nicotinealdehyde
ATE443045T1 (de) Verfahren zur herstellung von 1-halogen-2,7- naphthyridinylderivaten
WO2004085348A3 (en) Production of 5-methyl-n-aryl-2-pyrrolidone and 5-methyl-n-alkyl-2-pyrrolidone
EP1661894A4 (de) Verfahren zur herstellung von 4-aminotetrahydropyranen und deren salzen mit säuren, zwischenprodukte für das verfahren und verfahren zur herstellung davon
JP4478827B2 (ja) アミンボランを用いるアミンの製造方法
EA200700897A1 (ru) Способ получения хирально чистой кристаллической модификации натеглинида
JPS63503384A (ja) 1‐置換(s)‐および(r)‐2‐アミノメチルピロリジン類の有効な立体保存的合成およびその中間体
JP4769464B2 (ja) アルコール化合物の製造方法
Ghasemi et al. Sulfuric acid {[3-(3-silicapropyl) sulfanyl] propyl} ester as a recyclable solid acid catalyst for the synthesis of α-amino nitriles